S-EPMC12675605 - Long-term outcomes and treatment patterns in Waldenstrom macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy. - OmicsDI

Unknown

Dataset Information

Long-term outcomes and treatment patterns in Waldenstrom macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.

ABSTRACT:

SUBMITTER: Chohan KL

PROVIDER: S-EPMC12675605 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature